Targeted gene integration therapy for cystinosis

Project Code

CMD27Br Saleem

Project Type

Wet lab

Research Theme

Cardiometabolic Disease

Project Summary Download

Summary

Cystinosis is a rare condition caused by mutations in the CTNS gene. This leads to cystine build-up in cells which damages many organs, especially the kidneys. The current treatment, cysteamine, slows the disease but many patients still develop serious complications. This project aims to develop a new, one-time gene therapy that provides a lasting treatment for cystinosis, by integrating a healthy copy of the CTNS gene into cells. We will test whether this reduces the harmful cystine build-up. If successful, this work could lead to a single treatment that prevents serious multi-organ complications and improves quality of life in cystinosis.

Can the project be completed part time?

Yes

Lead Supervisor

Professor Moin Saleem

Lead Supervisor Email

m.saleem@bristol.ac.uk

University Affiliation

University of Bristol

Back to top ↑